Unequal access to cancer drugs – a long-standing issue for patients and oncologists – was to be remedied with the creation of the Joint Oncology Drug Review, to which all provinces but Quebec belong. Despite JODR's formation in March, 2007, the funding of some cancer drugs remains unequal across the country.{More}
“Here in Canada, it's still a postal-code lottery for cancer drugs,” said Bill Hryniuk, past chairman of the Cancer Advocacy Coalition of Canada.
{And more}
{And still more}
•
